STUDY OF ALLERGIZING ACTIVITY OF THE DRUG «NETINFLA №2»

Mualliflar

  • M.S. Khikmatova Tashkent pharmaceutical institute, Tashkent, Republic of Uzbekistan Muallif

Abstrak

Successful introduction of new medicines into clinical practice presupposes the proven safety of their use. For this purpose, it is important to conduct preclinical pilot studies. Scientific methods are used to assess and prove the safety of drugs, as a requisite for the use of new drugs created for the first time in humans is previous conduct of toxicological studies on laboratory animals. One of the necessary toxicological studies is the study of allergizing activity

Nashr qilingan

2024-06-30

Iqtibos keltirish tartibi

STUDY OF ALLERGIZING ACTIVITY OF THE DRUG «NETINFLA №2». (2024). Yevroosiyo Tibbiyot Va Tabiiy Fanlar Jurnali, 4(6 (Special Issue), 424-425. https://www.in-academy.uz/index.php/EJMNS/article/view/10638